Literature DB >> 18702458

Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenes.

Tijana Bugarcic1, Olga Nováková, Anna Halámiková, Lenka Zerzánková, Oldrich Vrána, Jana Kaspárková, Abraha Habtemariam, Simon Parsons, Peter J Sadler, Viktor Brabec.   

Abstract

We have compared the cancer cell cytotoxicity, cell uptake, and DNA binding properties of the isomeric terphenyl complexes [(eta(6)-arene)Ru(en)Cl](+), where the arene is ortho- (2), meta- (3), or para-terphenyl (1) (o-, m-, or p-terp). Complex 1, the X-ray crystal structure of which confirms that it has the classical "piano-stool" geometry, has a similar potency to cisplatin but is not cross-resistant and has a much higher activity than 2 or 3. The extent of Ru uptake into A2780 or A2780cis cells does not correlate with potency. Complex 1 binds to DNA rapidly and quantitatively, preferentially to guanine residues, and causes significant DNA unwinding. Circular and linear dichroism, competitive binding experiments with ethidium bromide, DNA melting, and surface-enhanced Raman spectroscopic data are consistent with combined intercalative and monofunctional (coordination) binding mode of complex 1. This unusual DNA binding mode may therefore make a major contribution to the high potency of complex 1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18702458     DOI: 10.1021/jm8003043

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  Antitumor carboplatin is more toxic in tumor cells when photoactivated: enhanced DNA binding.

Authors:  Jarmila Mlcouskova; Jana Stepankova; Viktor Brabec
Journal:  J Biol Inorg Chem       Date:  2012-05-26       Impact factor: 3.358

2.  Isomer separation and gas-phase configurations of organoruthenium anticancer complexes: ion mobility mass spectrometry and modeling.

Authors:  Jonathan P Williams; Tijana Bugarcic; Abraha Habtemariam; Kevin Giles; Iain Campuzano; P Mark Rodger; Peter J Sadler
Journal:  J Am Soc Mass Spectrom       Date:  2009-02-14       Impact factor: 3.109

Review 3.  The path for metal complexes to a DNA target.

Authors:  Alexis C Komor; Jacqueline K Barton
Journal:  Chem Commun (Camb)       Date:  2013-05-07       Impact factor: 6.222

4.  Insight into the toxic effects of cis-dichloridoplatinum(II) complexes containing 7-azaindole halogeno derivatives in tumor cells.

Authors:  Tereza Muchova; Jitka Pracharova; Pavel Starha; Radana Olivova; Oldrich Vrana; Barbora Benesova; Jana Kasparkova; Zdenek Travnicek; Viktor Brabec
Journal:  J Biol Inorg Chem       Date:  2013-05-15       Impact factor: 3.358

Review 5.  Unusual DNA binding modes for metal anticancer complexes.

Authors:  Ana M Pizarro; Peter J Sadler
Journal:  Biochimie       Date:  2009-04-01       Impact factor: 4.079

6.  Cytotoxicity, apoptosis, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential, and Western blotting analysis of ruthenium(II) complexes.

Authors:  Gan-Jian Lin; Guang-Bin Jiang; Yang-Yin Xie; Hong-Liang Huang; Zhen-Hua Liang; Yun-Jun Liu
Journal:  J Biol Inorg Chem       Date:  2013-08-30       Impact factor: 3.358

7.  Binding properties of Ru(II) polypyridyl complexes with poly(U)·poly(A)*poly(U) triplex: the ancillary ligand effect on third-strand stabilization.

Authors:  Li-Feng Tan; Ling-Jun Xie; Xiao-Nan Sun
Journal:  J Biol Inorg Chem       Date:  2012-10-31       Impact factor: 3.358

8.  Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.

Authors:  Soledad Betanzos-Lara; Olga Novakova; Robert J Deeth; Ana M Pizarro; Guy J Clarkson; Barbora Liskova; Viktor Brabec; Peter J Sadler; Abraha Habtemariam
Journal:  J Biol Inorg Chem       Date:  2012-07-12       Impact factor: 3.358

9.  Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Adv Inorg Chem       Date:  2009-07-07       Impact factor: 3.282

10.  Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells.

Authors:  Jerneja Kladnik; James P C Coverdale; Jakob Kljun; Hilke Burmeister; Petra Lippman; Francesca G Ellis; Alan M Jones; Ingo Ott; Isolda Romero-Canelón; Iztok Turel
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.